Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04710212 · ClinicalTrials.gov registry record
Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 168
- Enrollment target
NCT04710212 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 168 participants.
The verdict
NCT04710212 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 168 participants
- Enrollment target
Study Summary
This is a prospective, observational cohort study to assess the frequency with which neutropenic patients with hematologic malignancies and hematopoietic cell transplant (HCT) recipients are colonized with fluoroquinolone-resistant Enterobacterales (FQRE) and the clinical impact of FQRE colonization.
Interventions
- OTHER No intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2021-03-12 |
| Est. Completion | 2022-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04710212
The ClinicalTrials.gov registry entry for NCT04710212 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention. is the first listed.
NCT04710212 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04710212 about?
NCT04710212 is a clinical study titled "Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies". This is a prospective, observational cohort study to assess the frequency with which neutropenic patients with hematologic malignancies and hematopoietic cell transplant (HCT) recipients are colonized with fluoroquinolone-resistant Enterobacterales (FQRE) and the clinical impact of FQRE colonization...
What is the current status of trial NCT04710212?
This trial is currently completed. The enrollment target is 168 participants. The study started on 2021-03-12. Estimated completion is 2022-02-28.
What interventions are being tested in trial NCT04710212?
The interventions under investigation include: No intervention. (OTHER).
Who is sponsoring clinical trial NCT04710212?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.